These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17313962)

  • 1. Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
    Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
    Neuropharmacology; 2007 Mar; 52(4):1179-87. PubMed ID: 17313962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.
    Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
    Neuropharmacology; 2007 Sep; 53(3):379-89. PubMed ID: 17632185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
    Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
    Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
    Li Z; Prus AJ; Dai J; Meltzer HY
    J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy.
    Deutsch SI; Rosse RB; Schwartz BL; Schooler NR; Gaskins BL; Long KD; Mastropaolo J
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):147-51. PubMed ID: 17656074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
    Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
    Schilström B; Ivanov VB; Wiker C; Svensson TH
    Neuropsychopharmacology; 2007 Jan; 32(1):43-53. PubMed ID: 16641937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
    Noda Y; Nabeshima T
    Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.
    Sato M; Ago Y; Koda K; Nakamura S; Kawasaki T; Baba A; Matsuda T
    Eur J Pharmacol; 2007 Mar; 559(2-3):155-60. PubMed ID: 17258195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of medial prefrontal cortex neurons by phencyclidine is mediated via AMPA/kainate glutamate receptors in anesthetized rats.
    Katayama T; Jodo E; Suzuki Y; Hoshino KY; Takeuchi S; Kayama Y
    Neuroscience; 2007 Dec; 150(2):442-8. PubMed ID: 17935894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
    Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
    Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
    Yanagida T; Takeuchi H; Kitamura Y; Takata K; Minamino H; Shibaike T; Tsushima J; Kishimoto K; Yasui H; Taniguchi T; Shimohama S
    Neurosci Res; 2008 Dec; 62(4):254-61. PubMed ID: 18845194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
    Becker A; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavioral assessment of neuroleptics (3)--Schizophrenia negative symptoms-like model induced by PCP].
    Noda Y; Nabeshima T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):123-8. PubMed ID: 8905801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release.
    Ichikawa J; Chung YC; Dai J; Meltzer HY
    Brain Res; 2005 Aug; 1052(1):56-62. PubMed ID: 16061211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents.
    Gacsályi I; Nagy K; Pallagi K; Lévay G; Hársing LG; Móricz K; Kertész S; Varga P; Haller J; Gigler G; Szénási G; Barkóczy J; Bíró J; Spedding M; Antoni FA
    Neuropharmacology; 2013 Jan; 64():254-63. PubMed ID: 22824189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
    Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice.
    Tanaka K; Yagi T; Shimakoshi R; Azuma K; Nanba T; Ogo H; Tamura A; Asanuma M
    Neurosci Lett; 2009 Oct; 462(3):235-8. PubMed ID: 19615429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.